author-photo

Reva K Basho

Cedars-Sinai Medical Center

17

Papers

71

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

Evaluating the impact of age on immune checkpoint therapy biomarkers.

2021 Cell Reports
Show All
- Source
- Cite
- Save
Citations (1)
Analysis of immune checkpoint blockade biomarkers in elderly patients using large-scale cancer genomics data.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Incidence of PI3K pathway alteration and response to neoadjuvant therapy (NAT) in triple negative breast cancer (TNBC) subtypes.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Adjuvant endocrine therapy is associated with improved overall survival in elderly hormone receptor-positive breast cancer patients

2020 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (0)
COVID-19 in cancer patients: risk, clinical features, and management

2020 Cancer biology and medicine
Show All
- Source
- Cite
- Save
Citations (24)
Abstract OT3-04-02: Neoadjuvant Her2-targeted therapy +/- immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
287TiPNeoadjuvant HER2-targeted therapy with or without immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
SGNLVA-002: Single-arm, open label phase Ib/II study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of patients with unresectable locally advanced or metastatic triple-negative breast cancer.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (8)
Pembrolizumab (pembro) with paclitaxel (taxol) or capecitabine (cape) as early treatment of metastatic triple-negative breast cancer (mTNBC).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (10)
Abstract P2-09-07: Preoperative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC)

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (3)